MeSH tree: C15.378.463
An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation.
5 hours ago
0
0
Immunotherapy for cancer works like a guided missile, directing the body's immune cells toward tumor cells. However, not all immune cells respond to the call to attack, and this can lead to variability in treatment responses. ...
20 hours ago
0
3
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb, and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma. In two ...
May 18, 2026
0
4
When a baby is born, hospital staff move quickly through a standard checklist of newborn care: taking measurements, administering antibiotic eye ointment to prevent eye infections, and giving a small injection of vitamin ...
May 15, 2026
0
10
A study, led by experts at the University of Nottingham, has found that persistent and distressing upper gut symptoms experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), are not due to structural problems ...
May 13, 2026
0
5
Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly increased risk of hematologic SPMs, according to a review published online April 6 in Frontiers in Oncology.
Apr 30, 2026
0
5
Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited tools at their disposal to predict who is most likely to benefit or suffer from a particular myeloma ...
Apr 27, 2026
0
3
What if doctors could more accurately diagnose and monitor blood cancer with a simple blood draw? This vision is becoming a reality thanks to research at Rapid Novor, a Waterloo-based company co-founded by Dr. Bin Ma, a computer ...
Apr 26, 2026
0
11
For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an "identity crisis." Normally, a B cell matures into a plasma cell ...
Apr 24, 2026
0
7
Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma cells begin to multiply, ...
Apr 14, 2026
0
15
